English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Use of non-steroid anti-inflammatory drugs (NSAIDs) has been associated with decreased risk of breast cancer in epidemiological studies. Thus, a high-inflammatory response may be associated with increased breast cancer risk. It is thus possible that genetic variations leading to a modified inflammatory response will influence breast cancer risk. The purpose of this study was to determine if polymorphisms associated with an altered inflammatory response are associated with breast cancer risk, and to investigate the possible interaction with lifestyle factors such as alcohol use, smoking and NSAID use. We matched 361 female breast cancer cases with 361 controls, nested within the prospective ‘Diet, Cancer and Health’ study. Carriers of the variant Ala-allele ofPPARγ2Pro12Ala were at lower risk of breast cancer (IRR = 0.67, 95% CI = 0.46–0.97). This was primarily due to an interaction with alcohol consumption. Alcohol consumption was associated with a 1.21-fold increased risk of breast cancer per 10 g alcohol/day (95% CI = 1.06–1.35) among homozygous wild-type carriers, whereas alcohol was not associated with breast cancer risk among variant allele carriers (Pfor interaction = 0.005). Non-users of NSAID, who were carriers of the variant allele ofPPARγ2Pro12Ala, were at lower risk of breast cancer (IRR = 0.44; 95% CI = 0.26–0.73) compared with non-users carrying wild-type alleles (Pfor interaction = 0.03). No effects were found forIL6G-174C,IL8T-251A andCOX2T8473C. Our results suggest thatPPARγ2Pro12Ala is an important determinant in alcohol mediated breast carcinogenesis. We also observe interaction between NSAID, alcohol consumption andPPARγ2Pro12Ala genotype in relation to breast cancer risk.

carcinogenesis

Peroxisome profilerator-activated receptorγ2 Pro              12              Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes